The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update - April 2016

13 Apr 2016 11:00

RNS Number : 0782V
Honeycomb Investment Trust PLC
13 April 2016
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

13 April 2016

 

 

Honeycomb Investment Trust plc ("Honeycomb" or the "Company")

Trading update

 

Further to the portfolio acquisition announcement of 7 April 2016 (the "April Portfolio Acquisition"), Honeycomb is releasing a trading update.

 

Based on the investments it has committed to and the currently available pipeline of investment opportunities, Honeycomb expects that the unlevered, net annual returns on loan investments as at full deployment of its IPO equity raise proceeds will be 12% or greater (after expected default losses and servicing costs), which compares favourably to the Company's targeted annual net return on loan investments of 10% or greater.

 

Since its IPO in late December 2015, the Company has been investing its capital quickly and effectively and is well on track to be fully deployed ahead of the six to nine month period targeted. On completion of the April Portfolio Acquisition, the Company's investment activity will have consisted of:

 

· Approximately £85 million invested in assets across portfolios and through organic origination partnerships;

· A diversified and seasoned portfolio of over 32,000 loans to UK borrowers;

· Regular origination is now occurring, principally through Freedom Finance at this stage, and a further 3 origination partners are being contracted with. Pay4Later has progressed well and retailer opportunities are being presented. Origination remains on track to increase to greater than £4m per month with a volume mix in line with expectations; and

· The intended investment in Pay4Later disclosed in the Company's IPO prospectus is expected to complete later this month, which will take equity investments up to approximately £4.7 million.

 

The Company continues to progress discussions and documentation with two major UK banks for the provision of up to £75 million of credit facilities to the Company, with the expectation of concluding the first facility, of approximately £40 million, within the coming weeks.

 

The Company targets dividends of 8% or greater on its shares issue price when fully invested and levered. Based on the expected net returns on loan investments being currently higher than targeted, the Company expects dividends, once fully invested and levered, will be at a rate of 10% or greater of its shares issue price; expected to be achieved for Q3 period of 2016.

 

Honeycomb continues to see a strong pipeline of opportunities to deploy funds in line with its returns targets, via the ongoing origination partnerships it has established and others it expects to add going forwards, as well as through further portfolio acquisitions, including the proposed acquisition of the second portfolio referred to in the April Portfolio Acquisition announcement. In light of this, the Company is now actively considering an issue of additional equity, subject to prevailing market conditions and investor demand.

 

Lindsey McMurray, chief executive of Pollen Street Capital Limited, investment manager of the Company, said: "We are glad to say Honeycomb has been delivering ahead of the plan set out to investors at its IPO. The first dividend is intended to be declared in May, and the prompt deployment of funds means that Honeycomb can move towards providing its shareholders with dividends ahead of its target during this year.

 

Opportunities continue to be strong in both portfolio acquisitions and organic origination through focusing on delivering high quality lending products in under-served markets"

 

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate.

 

This announcement contains certain statements about the future plans of the Company and expectations relating to its future financial condition, performance, results, strategy and objectives. These forward looking statements are based on the Company's current plans and expectations, and accordingly may be influenced by a number of factors that could cause actual outcomes to be materially different. The Company expressly disclaims any obligation to update any of the forward looking statements in this announcement

 

Enquiries:

Apex Fund Services (UK) Ltd.

Priya Dhaliah / Paul Spendiff / Robert Kelly020 3697 5368

Pollen Street Capital Limited

Chris Palmer / Johnathan Moyes020 3728 6750

Liberum

Simon Atkinson / Chris Clarke / Joshua Hughes020 3100 2000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUGCGDSIUBBGLX
Date   Source Headline
27th Jan 20206:26 pmRNSResult of Buy-Back and total voting rights
27th Jan 20204:08 pmRNSProposed Share Trade and Share Buy-Back
23rd Jan 20207:01 amRNSMonthly Update - December 2019
23rd Jan 20207:00 amRNSNet Asset Value(s)
20th Dec 20197:01 amRNSMonthly Update - November 2019
20th Dec 20197:00 amRNSNet Asset Value(s)
16th Dec 20191:51 pmRNSResult of General Meeting
29th Nov 20197:00 amRNSCircular and Notice of General Meeting
27th Nov 20197:01 amRNSMonthly Update - October 2019
27th Nov 20197:00 amRNSNet Asset Value(s)
19th Nov 20194:13 pmRNSHolding(s) in Company
8th Nov 20197:00 amRNSDividend Declaration
21st Oct 20197:01 amRNSMonthly Update - September 2019
21st Oct 20197:00 amRNSNet Asset Value(s)
30th Sep 20197:01 amRNSMonthly Update - August 2019
30th Sep 20197:00 amRNSNet Asset Value(s)
10th Sep 20197:00 amRNSHalf-year Report 2019
5th Sep 20193:02 pmRNSDividend Declaration
21st Aug 20197:01 amRNSMonthly Update - July 2019
21st Aug 20197:00 amRNSNet Asset Value(s)
12th Aug 20192:51 pmRNSPublication of Suppl.Prospcts
7th Aug 20195:13 pmRNSDirector/PDMR Shareholding
25th Jul 20197:01 amRNSMonthly Update - June 2019
25th Jul 20197:00 amRNSNet Asset Value(s)
25th Jun 201910:10 amRNSMonthly Update - 31 May 2019
25th Jun 201910:04 amRNSNet Asset Value(s)
14th Jun 20197:00 amRNSDirectorate Change
6th Jun 20195:33 pmRNSResult of AGM
21st May 20197:01 amRNSMonthly Update - 30 April 2019
21st May 20197:00 amRNSNet Asset Value(s)
3rd May 20192:46 pmRNSNotice of Annual Report & Director Resignation
29th Apr 20197:00 amRNSDividend Declaration
29th Apr 20197:00 amRNSAnnual Report and Audited Financial Statements
26th Apr 20197:01 amRNSMonthly Update - 31 March 2019
26th Apr 20197:00 amRNSNet Asset Value(s)
21st Mar 20197:01 amRNSMonthly Update - 28 February 2019
21st Mar 20197:00 amRNSNet Asset Value(s)
22nd Feb 20197:02 amRNSMonthly Update - 31 January 2019
22nd Feb 20197:01 amRNSDividend Declaration
22nd Feb 20197:00 amRNSNet Asset Value(s)
29th Jan 20197:01 amRNSFact Sheet December 2018
29th Jan 20197:00 amRNSNet Asset Value(s)
21st Dec 201812:49 pmRNSPlacing Programme: publication of prospectus
21st Dec 20187:01 amRNSMonthly Update - 30 November 2018
21st Dec 20187:00 amRNSNet Asset Value - 30 November 2018
22nd Nov 20187:01 amRNSMonthly Update - 31 October 2018
22nd Nov 20187:00 amRNSNet Asset Value - 31 October 2018
16th Nov 20187:00 amRNSDividend Declaration
23rd Oct 20187:01 amRNSMonthly Update - 30 September 2018
23rd Oct 20187:00 amRNSNet Asset Value - 30 September 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.